Researchers indentify new biomarkers of the most common lung cancer
TV3, Informatius
Josep Samitier
Group leader
Daniel Navajas: 30 years dedicated to mechanobiology
Last May 5, on the occasion of Professor Daniel Navajas’ retirement, the IBEC held the symposium Before Mechanobiology had a name. The event paid tribute to the IBEC researcher’s exciting … Read more
Researchers developed a chip to simulate the blood-brain barrier in the brain
A study led by IBEC researchers has made it possible to reproduce the blood-brain barrier using the organ-on-a-chip (OoC) platform with the ultimate goal of being able to study the … Read more
Nanomedicine experts meet to tackle rare diseases
Yesterday, experts in Nanomedicine from different fields gathered for the fourth consecutive year at the Nano Rare Diseases Day. This event is co-organized by the NANOMED Spain platform, coordinated by … Read more
Challenges and opportunities in biomedical research in the media
The XV Annual Conference of Biomedical Research Technology Platforms, in which Josep Samitier took part, is in the media because of the great revolution that biomedical research is undergoing thanks to new knowledge at the tissue, cellular and genomic levels.
Challenges and opportunities in biomedical research
The 15th Annual Conference of Biomedical Research Technology Platforms was held yesterday and, with more than 700 participants, it has become the reference forum for analyzing the main challenges and opportunities facing Spain in biomedical research. The event, which was attended by Josep Samitier, director of the Institute for Bioengineering of Catalonia (IBEC) and scientific coordinator of the Nanomed Spain platform, brought together representatives of the Administration, regulatory agencies, universities and companies, as well as clinical researchers and patients.
Josep Samitier, technology and health on “Ràdio Estel”
Josep Samitier, director of the Institute for Bioengineering of Catalonia, is interviewed on the program “Tot anirà bé” of “Ràdio Estel” for the technological and health advances that are being carried out at IBEC.
Complementary biotechnology plan presented at IBEC
The strategic research programme in the area of biotechnology applied to healthcare that was presented at the Institute for Bioengineering of Catalonia (IBEC), appears in the media by investing 32 million more in biotechnology.
IBEC leads the largest biotech consortium for healthcare in Spain
Yesterday, the strategic research programme in the area of biotechnology applied to healthcare was presented in Barcelona. The programme will be implemented through the Recovery and Resilience Mechanism Complementary Plans and will run until the end of 2024.
Researchers call for a change to the new law of science
